MMP2 and neoplasm: An MMP-2-cleavable GPLGLAG (GG) heptapeptide spacer34,35, was introduced into the PD7 POLY-PROTAC (namely, PGD7) to promote tumour-specific accumulation and cellular uptake of the POLY-PROTAC NPs (Supplementary Figs. 18–23).